Risk factors for Candida colonization/infection in non-neutropenic medical critically ill patients

Documenti analoghi

• Therapeutic variability in the treatment of Candida colonization/infection in non-neutropenic critically ill patients
  di: León, C, et al.
  Pubblicazione: (2001)
• Fluconazole prophylaxis of systemic candida infection in non-neutropenic critically ill patients: a prospective randomized study
  di: Parizkova, R, et al.
  Pubblicazione: (1999)
• Prevalence of candidemia and associated candida subtypes following severe sepsis in non-neutropenic critically ill patients
  di: Kashiha, Arefeh, et al.
  Pubblicazione: (2018)
• Predicting invasive fungal disease due to Candida species in non-neutropenic, critically ill, adult patients in United Kingdom critical care units
  di: Shahin, Jason, et al.
  Pubblicazione: (2016)
• Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patients
  di: Trof, R. J., et al.
  Pubblicazione: (2007)